Clinical Trials Logo

Clinical Trial Summary

This research protocol is designed to evaluate a novel imaging camera, only one of three of it's kind in existence, in the diagnosis of breast cancer. The Molecular Breast Imaging Camera (MBI) is a gamma camera that images accumulation of 99mTc-Sestamibi, a radiopharmaceutical with high affinity for tissues of high cellularity and mitochondrial content; a common characteristic of breast cancers.

This camera represents a significant advancement over its predecessors as it has improved imaging geometry since it can be in direct contact with breast tissue and improved gamma photon detection capability through the use of cadmium zinc telluride (CZT) crystals (a semiconductor material) instead of NaI used in standard gamma cameras.

This project involves imaging patients with a baseline population risk of breast cancer, referred for myocardial perfusion imaging (MPI). This is possible because 99mTc-sestamibi is also used to image myocardial tissue. After the MPI study is performed to standard clinical specifications, the patient is simply imaged with the MBI.

The primary endpoint of this project is to assess acceptability of this imaging device by the patient through the use of a patient survey. Secondary endpoints are to correlate any findings on the MBI studies with standard breast imaging modalities including mammogram, ultrasound, and MRI. Image quality will be evaluated by the interpreting physicians. Also, in an effort to reduce radiation absorbed dose to the female breast, low injected dose images, obtained through post-processing by reframing acquired images, will be assessed for acceptable image quality and diagnostic accuracy.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01368939
Study type Observational
Source Hamilton Health Sciences Corporation
Contact Tammy Murray
Phone 905-522-1155
Email tmurray@stjosham.on.ca
Status Recruiting
Phase N/A
Start date March 2012
Completion date June 2013

See also
  Status Clinical Trial Phase
Terminated NCT03520127 - A Registry Study Evaluating Outcomes in Breast Biopsy With the Intactâ„¢ Breast Lesion Excision System (BLES)
Active, not recruiting NCT03706534 - Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms N/A
Completed NCT00599105 - Angiogenesis in Early Breast Cancer for Prognosis Prediction N/A
Terminated NCT00934297 - Visualization Tool for Investigation of Breast Lesions N/A
Completed NCT03020888 - Magseed Magnetic Marker Localization N/A
Unknown status NCT00671385 - Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning N/A
Recruiting NCT05118295 - Single Step Lesion Annotation and Localization of Suspicious Breast Lesions Early Phase 1